how many people are on glp 1 drugs New Weight Loss Drugs: GLP-1 Agonist Use and Side Effects in the United States Brain scientists are seeking weight-loss

reported in a propensity score-matched population-based cohort analysis that GLP-1 receptor agonist use in patients with MASLD and type 2 diabetes was associated with a lower risk of HCC (aHR: 0.55, 95%CI: 0.44-0.69) and all-cause mortality (aHR: 0.62, 95%CI: 0.55-0.71) [59]

[138] found aberrant CpG methylation of APP , MAPT , and GSK3B in AD brain

Conclusion Oral BPC-157 decreases inflammation in the mouth and stomach by repairing mucosal barriers, modulating cytokines, reducing oxidative stress, and promoting angiogenesis and collagen synthesis

Lower Cost: The current "GLP-1 Patches" on the market are roughly $1 per day, which is a lot cheaper than other GLP-1 options on the market

This allows for more immediate systemic availability and the possibility of localized administration near an injury site